These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12716241)

  • 1. Intravenous fosphenytoin in acute mania.
    Applebaum J; Levine J; Belmaker RH
    J Clin Psychiatry; 2003 Apr; 64(4):408-9. PubMed ID: 12716241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin as an antimanic anticonvulsant: a controlled study.
    Mishory A; Yaroslavsky Y; Bersudsky Y; Belmaker RH
    Am J Psychiatry; 2000 Mar; 157(3):463-5. PubMed ID: 10698828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
    Knapp LE; Kugler AR
    J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design.
    Grunze HC; Normann C; Langosch J; Schaefer M; Amann B; Sterr A; Schloesser S; Kleindienst N; Walden J
    J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose intravenous valproate in acute mania.
    Phrolov K; Applebaum J; Levine J; Miodovnick H; Belmaker RH
    J Clin Psychiatry; 2004 Jan; 65(1):68-70. PubMed ID: 14744171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosphenytoin in infants.
    Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS
    J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosphenytoin: a novel phenytoin prodrug.
    Boucher BA
    Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosphenytoin.
    Eriksson K; Keränen T; Kälviäinen R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosphenytoin. Pharmacoeconomic implications of therapy.
    Holliday SM; Benfield P; Plosker GL
    Pharmacoeconomics; 1998 Dec; 14(6):685-90. PubMed ID: 10346419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.
    DeToledo JC; Ramsay RE
    Drug Saf; 2000 Jun; 22(6):459-66. PubMed ID: 10877039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin.
    Ramsay RE; Wilder BJ; Uthman BM; Garnett WR; Pellock JM; Barkley GL; Leppik IE; Knapp LE
    Epilepsy Res; 1997 Oct; 28(3):181-7. PubMed ID: 9332883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
    J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous valproate loading in acutely manic and depressed bipolar I patients.
    Grunze H; Erfurth A; Amann B; Giupponi G; Kammerer C; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):303-9. PubMed ID: 10440456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.